Investor Gets 1 Year For Insider Trading On Gilead Buy
A Florida man who copped to his role in an insider trading scheme stemming from Gilead Sciences Inc.'s $11 billion acquisition of New Jersey-based Pharmasset Inc., which made the latter company's...To view the full article, register now.
Already a subscriber? Click here to view full article